Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients
about
Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Upregulation of CD4+T-Cell Der ...... of Multiple Sclerosis Patients
@en
Upregulation of CD4+T-Cell Der ...... f Multiple Sclerosis Patients.
@nl
type
label
Upregulation of CD4+T-Cell Der ...... of Multiple Sclerosis Patients
@en
Upregulation of CD4+T-Cell Der ...... f Multiple Sclerosis Patients.
@nl
prefLabel
Upregulation of CD4+T-Cell Der ...... of Multiple Sclerosis Patients
@en
Upregulation of CD4+T-Cell Der ...... f Multiple Sclerosis Patients.
@nl
P2093
P2860
P356
P1433
P1476
Upregulation of CD4+T-Cell Der ...... of Multiple Sclerosis Patients
@en
P2093
Aref Hosseini
Kamran Ghaedi
Masoud Etemadifar
Mazdak Ganjalikhani-Hakemi
Mohammad Hossein Nasr Esfahani
Shohreh Teimuri
Somayeh Tanhaei
P2860
P304
P356
10.22074/CELLJ.2016.4565
P577
2016-08-24T00:00:00Z